Evidence map›Paper›PMID 39275147›Full record

Trial reportNutrients2024

Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation on Clinical Outcome of Atopic Dermatitis in Children.

Tena Niseteo, Iva Hojsak, Suzana Ožanić Bulić, Nives Pustišek

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Brianolide fromBiomolecules · 2025
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tena NiseteoReferral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, 10000 Zagreb, Croatia.ORCID 0000-0003-0170-7705
Iva HojsakReferral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, 10000 Zagreb, Croatia.
Suzana Ožanić BulićDepartment of Pediatric and Adolescent Dermatology and Venerology, Children's Hospital Zagreb, 10000 Zagreb, Croatia.
Nives PustišekDepartment of Pediatric and Adolescent Dermatology and Venerology, Children's Hospital Zagreb, 10000 Zagreb, Croatia.

Funding

4U pharma, gmbh, Swicerland no grant number
6 · The paper itself

Abstract

The use of omega-3 fatty acids (omega-3 FA) in the treatment of atopic dermatitis (AD) is an area of ongoing research. Some studies suggest that dietary supplementation with omega-3 FA can help manage symptoms of AD by reducing lesion severity, skin inflammation, dryness and itching, while others show no significant beneficial effect. The aim of this study was to evaluate the effect of omega-3 FA from fish oil in combination with gamma-linolenic acid (GLA) from blackcurrant seed oil in children with AD. This is a longitudinal, prospective, randomized, triple blind, placebo-controlled parallel clinical trial. The study was conducted during the 2-year period throughout autumn, winter, and spring, avoiding the summer when AD usually improves. Children were randomized to receive the active study product (Mega Kid

Indexed as

Dermatitis, AtopicDietary SupplementsFatty Acids, Omega-3gamma-Linolenic AcidChildChild, PreschoolFemaleHumansLongitudinal StudiesMaleProspective StudiesPruritusQuality of LifeSeverity of Illness IndexTreatment OutcomeFatty Acids, Omega-3gamma-Linolenic Acidatopic dermatitischildrendocosahexaenoic acid (DHA)eicosapentaenoic acid (EPA)gamma-linolenic acid (GLA)omega-3 fatty acids

Identifiers

PMID39275147
PMCPMC11397185

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.